Cargando…
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
Autores principales: | Pabst, Gabriel, Lind, Karin, Graf, Ricarda, Zebisch, Armin, Stölzel, Friedrich, Döhner, Konstanze, Heitzer, Ellen, Reinisch, Andreas, Sill, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060155/ https://www.ncbi.nlm.nih.gov/pubmed/32002654 http://dx.doi.org/10.1007/s00277-020-03920-y |
Ejemplares similares
-
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
por: Prochazka, Katharina T., et al.
Publicado: (2019) -
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions
por: Müller, Marian, et al.
Publicado: (2019) -
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
por: Dutta, Sayantanee, et al.
Publicado: (2020) -
A Humanized Ossicle-niche Xenotransplantation Model Enables Improved Human Leukemic Engraftment
por: Reinisch, Andreas, et al.
Publicado: (2016) -
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)